Related Experiment Video
Updated: May 29, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
High cell surface death receptor expression determines type I versus type II signaling
Xue Wei Meng1, Kevin L Peterson2, Haiming Dai2
1Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905; Department of Molecular Pharmacology, Mayo Clinic, Rochester, Minnesota 55905.
The Fas receptor triggers apoptosis via two pathways: Type I and Type II. This study reveals cell surface death receptor expression levels dictate which pathway is used, clarifying the biochemical basis for this dichotomy.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Apoptosis, or programmed cell death, is crucial for development and tissue homeostasis.
- Fas receptor (also known as CD95 or APO-1) ligation initiates apoptosis through distinct Type I and Type II signaling pathways.
- The underlying molecular mechanisms differentiating Type I and Type II Fas signaling have remained elusive.
Purpose of the Study:
- To elucidate the biochemical basis for the Type I/Type II dichotomy in Fas-mediated apoptosis.
- To investigate the role of cell surface death receptor expression levels in determining signaling pathway choice.
- To explore whether this dichotomy is specific to the Fas receptor or a general feature of death receptor signaling.
Main Methods:
- Quantitative analysis of Fas mRNA half-life and cell surface Fas receptor expression.
- Manipulation of Fas receptor expression levels using forced overexpression and shRNA-mediated knockdown.
- Assessment of apoptosis induction and signaling pathway activation in response to receptor modulation.
- Comparative analysis of Fas and TRAIL (TNF-α-related apoptosis-inducing ligand) signaling pathways.
- Drug-induced modulation of death receptor 5 (DR5) expression.
Main Results:
- Type I cells exhibit longer Fas mRNA half-life and higher cell surface Fas levels compared to Type II cells.
- Forced overexpression of Fas receptor in Type II cells converted signaling to Type I.
- Fas receptor downregulation in Type I cells shifted signaling towards Type II.
- The same cells could utilize Type I for Fas and Type II for TRAIL signaling, indicating receptor specificity.
- Upregulation of DR5 converted TRAIL signaling from Type II to Type I.
Conclusions:
- Cell surface death receptor expression levels are the primary determinant of the Type I/Type II signaling dichotomy.
- This mechanism is not exclusive to the Fas receptor but applies to other death receptors like TRAIL.
- Understanding this dichotomy provides insights into regulating apoptosis for therapeutic interventions.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
Related Concept Videos
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Types of Receptors: Cell Surface Receptors
Cell-surface Signaling
Cellular Injury IlI: Cellular Death